DianeFayeHaleMD

PubMed

• Tumor infiltrating lymphocytes as an endpoint in cancer vaccine trials.
  Patrick M McCarthy, Franklin A Valdera, Todd R Smolinsky, Alexandra M Adams, Anne E O'Shea, Katryna K Thomas, Spencer Van Decar, Elizabeth L Carpenter, Ankur Tiwari, J...> ;Frontiers in Immunology. 2023 Jan 1
• 4 citations
  Maximizing Benefit of Virtual Learning: Lessons From the Coronavirus Disease 2019 Pandemic.
  Elizabeth L Carpenter, Alexandra M Adams, Robert C Chick, Mamie C Stull, Diane F Hale, Brandon W Propper, Guy T Clifton, Timothy J Vreeland> ;The Journal of Surgical Research. 2022 Jul 1
• 2 citations
  Safety and efficacy of autologous tumor lysate particle-loaded dendritic cell vaccination in combination with systemic therapies in patients with recurrent and metasta...
  Adams, A., Chick, R., Vreeland, T., Clifton, G., Hale, D., McCarthy, P., O'Shea, A., Bohan, P., Hickerson, A., Park, H., Sloan, A., Hyngstrom, J., Berger, A., Jakub, J...> ;Melanoma Research. 2021 Aug 1
• 15 citations
  Subgroup analysis of nelipepimut-S plus GM-CSF combined with trastuzumab versus trastuzumab alone to prevent recurrences in patients with high-risk, HER2 low-expressin...
  R. Connor Chick, G. Travis Clifton, Diane F. Hale, Timothy J. Vreeland, Phillip M. Kemp Bohan, Patrick M. McCarthy, Jennifer K. Litton, Gheath Alatrash, Rashmi Krishna...> ;Clinical Immunology. 2021 Jan 22
• 6 citations
  An Educational Intervention Reduces Opioids Prescribed Following General Surgery Procedures.
  Phillip M. Kemp Bohan, Robert C. Chick, Morgan E. Wall, Diane F. Hale, Ching Wei D. Tzeng, George E. Peoples, T. Vreeland, G. Travis Clifton> ;The Journal of Surgical Research. 2021 Jan 1
• 29 citations
  Chemoprevention in familial adenomatous polyposis: past, present and future.
  Phillip M. Kemp Bohan, Gautam Mankaney, Timothy J. Vreeland, Robert C. Chick, Diane F. Hale, Daniel C. Ensley, Vance Y. Sohn, G. Travis Clifton, George E. Peoples, Car...> ;Familial Cancer. 2021 Jan 1
• 8 citations
  Correlation of tumor microenvironment from biopsy and resection specimens in untreated colorectal cancer patients: a surprising lack of agreement
  Phillip M. Kemp Bohan, Robert C. Chick, Lynn Messersmith, Grant M. Williams, Jamie Lombardo, Ryan Collins, Robert Brady, Diane F. Hale, George E. Peoples, Timothy J. V...> ;Cancer Immunology, Immunotherapy. 2021 May 1
• 47 citations
  Results of a Randomized Phase IIb Trial of Nelipepimut-S + Trastuzumab versus Trastuzumab to Prevent Recurrences in Patients with High-Risk HER2 Low-Expressing Breast ...
  G. Travis Clifton, Diane F. Hale, Timothy J. Vreeland, Jennifer K. Litton, Gheath Alatrash, Rashmi Krishna Murthy, Na Qiao, Anne V. Philips, Jason Lukas, Jarrod P. Hol...> ;Clinical Cancer Research. 2020 Jun 1
• 33 citations
  Prospective, randomized, single-blinded, multi-center phase II trial of two HER2 peptide vaccines, GP2 and AE37, in breast cancer patients to prevent recurrence
  Tommy A. Brown, Elizabeth A. Mittendorf, Diane F. Hale, John W. Myers, Kaitlin M. Peace, Doreen O. Jackson, Julia M. Greene, Timothy J. Vreeland, G. Travis Clifton, Al...> ;Breast Cancer Research and Treatment. 2020 Apr 22
• 371 citations
  Using Technology to Maintain the Education of Residents During the COVID-19 Pandemic.
  Robert C. Chick, Guy T. Clifton, Kaitlin M. Peace, Brandon W. Propper, Diane F. Hale, Adnan Alseidi, Timothy J. Vreeland> ;Journal of Surgical Education. 2020 Apr 3
• 18 citations
  Final analysis of a phase I/IIa trial of the folate-binding protein-derived E39 peptide vaccine to prevent recurrence in ovarian and endometrial cancer patients.
  Tommy A. Brown, Kevin Byrd, Timothy J. Vreeland, Guy T. Clifton, Doreen O. Jackson, Diane F. Hale, Garth S. Herbert, John W. Myers, Julia M. Greene, John S. Berry, Jon...> ;Cancer Medicine. 2019 Aug 1
• 12 citations
  Initial safety analysis of a randomized phase II trial of nelipepimut-S + GM-CSF and trastuzumab compared to trastuzumab alone to prevent recurrence in breast cancer p...
  G. Travis Clifton, Kaitlin M. Peace, Jarrod P. Holmes, Timothy J. Vreeland, Diane F. Hale, Garth S. Herbert, Jennifer K. Litton, Rashmi Krishna Murthy, Jason Jerome Lu...> ;Clinical Immunology. 2019 Apr 1
• Effects of HLA status and HER2 status on outcomes in breast cancer patients at risk for recurrence - Implications for vaccine trial design.
  Jackson, D. O.,Trappey, F. A.,Clifton, G. T.,Vreeland, T. J.,Peace, K. M.,Hale, D. F.,Litton, J. K.,Murray, J. L.,Perez, S. A.,Papamichail, M.,Mittendorf, E. A.,People...> ;Clin. Immunol.. 2018 Jul 22
• 16 citations
  Initial phase I/IIa trial results of an autologous tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine in patients with solid tumors.
  Garth S. Herbert, Timothy J. Vreeland, Guy T. Clifton, Julia M. Greene, Doreen O. Jackson, Mark O. Hardin, Diane F. Hale, John S. Berry, Pauline Nichol, Sook Yin, Xian...> ;Vaccine. 2018 May 31
• 9 citations
  Tumor lysate particle loaded dendritic cell vaccine: preclinical testing of a novel personalized cancer vaccine.
  Mark O. Hardin, Timothy J. Vreeland, Guy T. Clifton, Diane F. Hale, Garth S. Herbert, Julia M. Greene, Doreen O. Jackson, John E Berry, Pauline Nichols, Sook Yin, Xian...> ;Immunotherapy. 2018 Apr 1
• Surgical Instrument Sets for Special Operations Expeditionary Surgical Teams.
  Diane F Hale, Justin C Sexton, Linda C Benavides, Jerry M Benavides, Jonathan B Lundy> ;Journal of Special Operations Medicine. 2017 Sep 15
• The Golden Hour Offset Surgical Treatment Team Operational Concept: Experience of the 102nd Forward Surgical Team in Operation Freedom's Sentinel 2015-2016.
  Jerry M Benavides, Linda C Benavides, Diane F Hale, Jonathan B Lundy> ;Journal of Special Operations Medicine. 2017 Sep 15
• 2 citations
  Routine Pre-Treatment MRI for Breast Cancer in a Single-Payer Medical Center: Effects on Surgical Choices, Timing and Outcomes.
  Timothy J. Vreeland, John S. Berry, Erika J Schneble, Doreen O. Jackson, Garth S. Herbert, Diane F. Hale, Jonathon M Martin, Madeline Flores, Adam R Pattyn, Kai W. Hat...> ;Journal of Cancer. 2017 Jul 23
• 26 citations
  Cancer vaccines in colon and rectal cancer over the last decade: lessons learned and future directions.
  John S. Berry, Timothy J. Vreeland, Alfred F. Trappey, Diane F. Hale, Kaitlin M. Peace, Joshua A. Tyler, Avery Walker, Ramon Brown, Garth S. Herbert, Fia Yi, Doreen O....> ;Expert Review of Clinical Immunology. 2017 Mar 4
• 8 citations
  Interim analysis of a phase I/IIa trial assessing E39+GM-CSF, a folate binding protein vaccine, to prevent recurrence in ovarian and endometrial cancer patients
  Doreen O. Jackson, Kevin Byrd, Timothy J. Vreeland, Diane F. Hale, Garth S. Herbert, Julia M. Greene, Erika J Schneble, John S. Berry, Alfred F. Trappey, Guy T. Clifto...> ;Oncotarget. 2017 Feb 28
• 5 citations
  Evaluation of attenuated tumor antigens and the implications for peptide-based cancer vaccine development
  John S. Berry, Timothy J. Vreeland, D F Hale, Doreen O. Jackson, Alfred F. Trappey, Julia M. Greene, Mark O. Hardin, Garth S. Herbert, Guy T. Clifton, George E. Peoples> ;Journal of Cancer. 2017 May 11
• 72 citations
  Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide GP2 vaccine in breast cancer patients to prevent recurrence
  Elizabeth A. Mittendorf, Alexandros Ardavanis, Jennifer K. Litton, Nathan M. Shumway, Diane F. Hale, James L. Murray, Sonia A. Perez, Sathibalan Ponniah, Constantin N....> ;Oncotarget. 2016 Aug 31
• 67 citations
  Primary Analysis of a Prospective, Randomized, Single-Blinded Phase II Trial Evaluating the HER2 Peptide AE37 Vaccine in Breast Cancer Patients to Prevent Recurrence
  Elizabeth A. Mittendorf, Alexandros Ardavanis, James T. Symanowski, James L. Murray, Nathan M. Shumway, Jennifer K. Litton, Diane F. Hale, Sonia A. Perez, Eleftheria A...> ;Annals of Oncology. 2016 Mar 30
• 24 citations
  Gaining ground on a cure through synergy: combining checkpoint inhibitors with cancer vaccines.
  Timothy J. Vreeland, Guy T. Clifton, Garth S. Herbert, Diane F. Hale, Doreen O. Jackson, John S. Berry, George E. Peoples> ;Expert Review of Clinical Immunology. 2016 Jun 28
• A phase I/IIa clinical trial in stage IV melanoma of an autologous tumor-dendritic cell fusion (dendritoma) vaccine with low dose interleukin-2.
  Greene JM, Schneble EJ, Jackson DO, Hale DF, Vreeland TJ, Flores M, Martin J, Herbert GS, Hardin MO, Yu X, Wagner TE, Peoples GE> ;Cancer Immunol Immunother. 2016 Apr
• Join now to see all